DMPK & Clinical Pharmacology

Advanced modeling and simulation expertise to optimize drug development decisions

Comprehensive Pharmacology Services

Our DMPK and Clinical Pharmacology team brings deep expertise in quantitative pharmacology, providing critical insights throughout the drug development lifecycle. We leverage advanced modeling and simulation techniques to inform key decisions from preclinical development through regulatory approval.

Core Capabilities

  • Non-compartmental Analysis (NCA)
  • Population PK/PD Modeling
  • Disease Progression Modeling
  • Quantitative Systems Pharmacology (QSP)

Therapeutic Areas

  • Oncology
  • Cardiovascular & Metabolic Diseases
  • Neuroscience
  • Rare Diseases

Our Expertise

Non-Compartmental Analysis

Comprehensive NCA services for all phases of clinical development:

  • • PK parameter estimation
  • • Bioequivalence assessments
  • • Food effect studies
  • • Drug-drug interaction analysis
  • • Special population studies

Population PK/PD Modeling

Advanced population modeling to inform critical development decisions:

  • • Dose optimization strategies
  • • Covariate analysis
  • • Exposure-response relationships
  • • Clinical trial simulations
  • • Pediatric dose extrapolation

Disease Progression Modeling

Quantitative understanding of disease trajectory and treatment effects:

  • • Natural history modeling
  • • Biomarker trajectory analysis
  • • Treatment effect quantification
  • • Long-term outcome predictions
  • • Clinical endpoint modeling

Quantitative Systems Pharmacology

Mechanistic modeling to bridge biology and clinical outcomes:

  • • Pathway-based modeling
  • • Target engagement assessment
  • • Combination therapy optimization
  • • Translational predictions
  • • Biomarker identification

Why Choose Kalvion Sciences for DMPK & Clinical Pharmacology

Scientific Excellence

PhD-level scientists with extensive experience in pharmacometrics and regulatory submissions

Regulatory Expertise

Deep understanding of FDA, EMA, and global regulatory requirements for modeling and simulation

Integrated Approach

Seamless integration with clinical development teams to maximize the impact of pharmacometric analyses

Ready to Optimize Your Drug Development?

Let our experts help you leverage the power of modeling and simulation to make better development decisions.

Get Started